EKF Diagnostics Holdings PLC LYF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €0.28
- Day Range
- €0.28–0.28
- 52-Week Range
- —–—
- Bid/Ask
- €0.00 / €0.00
- Shares Outstanding
- 427.97M
- Market Cap
- €119.83M
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 49.77
- Price/Sales
- 2.08
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 4.60%
Company Profile
EKF Diagnostics Holdings PLC is engaged in development, manufacture and supply of products and services into the in-vitro diagnostic (IVD) market place. The Group has presence in the UK, USA, Germany, and Russia, and sells throughout the world including Europe, the Middle East, the Americas, Asia, and Africa. It derive their revenue from the manufacture and sale of medical diagnostic equipment and reagents. Other services include the servicing and distribution of third party company products under separate distribution agreements.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 301
- Website
- https://www.ekfdiagnostics.com
Valuation
|
Metric
|
LYF
|
|---|---|
Price/Earnings (Normalized) | 49.77 |
Price/Book Value | 1.48 |
Price/Sales | 2.08 |
Price/Cash Flow | 11.77 |
Price/Earnings
LYF
Financial Strength
|
Metric
|
LYF
|
|---|---|
Quick Ratio | 3.03 |
Current Ratio | 4.72 |
Interest Coverage | 41.74 |
Quick Ratio
LYF
Profitability
|
Metric
|
LYF
|
|---|---|
Return on Assets (Normalized) | 3.64% |
Return on Equity (Normalized) | 4.23% |
Return on Invested Capital (Normalized) | 3.92% |
Return on Assets
LYF
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|DldR$#& | LOCK|!nvB | $181B | |||
| Medtronic PLC
MDT
| LOCK|?$m&pCS | LOCK|^P$r | $121B | |||
| Stryker Corp
SYK
| LOCK|&!<yWm&M | LOCK|WV< | $113B | |||
| Boston Scientific Corp
BSX
| LOCK|NN$cP<c | LOCK|$hS# | $64B | |||
| Edwards Lifesciences Corp
EW
| LOCK|S>X!Cp% | LOCK|n$sh | $50B | |||
| DexCom Inc
DXCM
| LOCK|X^<DJB! | LOCK|tmm@ | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|Bm%kjX$ | LOCK|!H | $31B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|lf? | LOCK|$xJ | $25B | |||
| Steris PLC
STE
| LOCK|WfK@p@K | LOCK|cR<^ | $22B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|jzl@lQ?q | LOCK|n? | $18B |
United States